| Literature DB >> 18652672 |
Wolfgang E Reintsch1, Craig A Mandato.
Abstract
In recent years proteomic techniques have started to become very useful tools in a variety of model systems of developmental biology. Applications cover many different aspects of development, including the characterization of changes in the proteome during early embryonic stages. During early animal development the embryo becomes patterned through the temporally and spatially controlled activation of distinct sets of genes. Patterning information is then translated, from gastrulation onwards, into regional specific morphogenetic cell and tissue movements that give the embryo its characteristic shape. On the molecular level, patterning is the outcome of intercellular communication via signaling molecules and the local activation or repression of transcription factors. Genetic approaches have been used very successfully to elucidate the processes behind these events. Morphogenetic movements, on the other hand, have to be orchestrated through regional changes in the mechanical properties of cells. The molecular mechanisms that govern these changes have remained much more elusive, at least in part due to the fact that they are more under translational/posttranslational control than patterning events. However, recent studies indicate that proteomic approaches can provide the means to finally unravel the mechanisms that link patterning to the generation of embryonic form. To intensify research in this direction will require close collaboration between proteome scientists and developmental researchers. It is with this aim in mind that we first give an outline of the classical questions of patterning and morphogenesis. We then summarize the proteomic approaches that have been applied in developmental model systems and describe the pioneering studies that have been done to study morphogenesis. Finally we discuss current and future strategies that will allow characterizing the changes in the embryonic proteome and ultimately lead to a deeper understanding of the cellular mechanisms that govern the generation of embryonic form.Entities:
Year: 2008 PMID: 18652672 PMCID: PMC2516511 DOI: 10.1186/1477-5956-6-21
Source DB: PubMed Journal: Proteome Sci ISSN: 1477-5956 Impact factor: 2.480
Use of proteomics in developmental studies.
| Zebrafish | 72 (hatching) and 120 hpf (larvae) | 2D LC ESI-MS/MS Temporal proteome | 1112 pr. (72 hpf) 867 pr. (120 hpf) | [ |
| Zebrafish | 72 (hatching) and 120 hpf (larvae) | 2D PAGE MALDI TOF/TOF Temporal proteome | 348 pr. (72 hpf) 317 pr. (120 hpf) | [ |
| Zebrafish | 24 hpf | SCX-TiO2-LC MS/MS Phosphoproteome | 604 phoshorylated pr. | [ |
| Zebrafish | 24 hpf wild-type and Fyn/Yes knock down embryos | SCX-TiO2-LC MS/MS Phosphoproteome | 141 pr., differentially phosphorylated | [ |
| Zebrafish | 7 hpf (early gastrula) | DIGE LC MS/MS Tissue proteome | 35 differentially expressed pr. between mesoderm and ectoderm | [ |
| Zebrafish | 6h-1 week pf (pregastrula-larvae stage) | 2D PAGE MALDI TOF/TOF Temporal proteome | 55 differentially expressed pr. | [ |
| Zebrafish | 2dpf, cloche mutant and wild-type | 2D PAGE MS/MS (-) | γ-cristallin downregulated in cloche mutants | [ |
| Drosophila | 0 h–24 h (combined) | SCX-IMAC-LC MS/MS Phosphoproteome | 2702 phosphorylated pr. | [ |
| Drosophila | Embryos (0–22 h), adult heads | SCX LC MS/MS Temporal proteome | 660 respectively 780 pr., 307 pr. in both stages | [ |
| Drosophila | gastrula-stages | DIGE MALDI TOF/TOF Tissue proteome | 37 differentially expressed pr. between lateral and ventral tissue | [ |
| C.elegans | Mixed stages | SCX LC-MS/MS Purified proteoglycans | 9 novel chondroitin proteoglycans | [ |
| C.elegans | embryo, L1-L4 larvae, adult | DIGE MALDI TOF Temporal proteome | 165 pr. expression profile | [ |
| chick | Matrix vesicles | SDS-PAGE LC MS/MS Organelle proteome | 126 pr. | [ |
| chick | ED 7 and 11 retina tissue | 2D PAGE MALDI TOF Temporal proteome | 13 pr., differentially expressed | [ |
| chick | Stage 29 (6 days) | 2D PAGE MALDI TOF Tissue proteome | 105 pr. | [ |
| Rat | ED 11.5 embryo vs. Yolk sac membrane | 2D PAGE MALDI MS/MS Tissue proteome | 430 tissue specific pr. spots | [ |
| mouse | Brain tissue ED 9.5, 11.5, 13.5 | DIGE ESI MS/MS Temporal proteome | 195 pr. differentially regulated | [ |
| mouse | Brain tissue ED 16 and postnatal | 2D PAGE MS Tissue proteome | ~10 pr. | [ |
| mouse | Brain tissue ED 16,5 | SCX LC MS/MS Phosphoproteome | 546 phosphorylation sites | [ |
| mouse | ED 8.5, 9.5, 10.5 neural tube closure | 2D PAGE ESI MS/MS Temporal proteome | 14 pr. upregulated at ED 10.5 | [ |
| Sea urchin | Egg, pre-post-fertilized | 2D PAGE MS/MS Phosphoproteome | 94 pr. show changes after fertilization | [ |
| Artemia | Diapause | 2D PAGE LS MS/MS Temporal proteome | 33 pr. | [ |
| Artemia | Postdiapaused cysts (0–20 h) | 2D PAGE MALDI TOF/TOF Temporal proteome | 75 pr. differentially expressed | [ |
| Rana catesbeiana | Tadpole (tailfin) | 2D-PAGE or iTRAQ-MS/MS Temporal proteome | 17 pr. differentially expressed after Thyroid treatment | [ |
A summary of published results on the use of proteomics in different model systems of developmental biology (pf = postfertilization, pr = proteins)